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Introduction
Duplication in TANK-binding kinase 1 (TBK1) gene has
been shown to be associated with normal tension glaucoma
(NTG), a subtype of the neurodegenerative disease glau-
coma, which is the largest cause of irreversible blindness.
A speciﬁc Taqman assay was used in exploring the genetic
contribution of the duplication in TBK1 on 158 NTG and
161 high tension glaucoma (HTG) patients as well as in 197
controls from West Bengal, eastern part of India. We iden-
tiﬁed two patients in NTG subgroup harbouring the dupli-
cation (1.26%). Both the patients harboured one extra copy
for the genomic segment analysed. No copy number change
was observed in the HTG subgroup or in the controls. This
is the ﬁrst report showing presence of duplication in TBK1 in
Indian primary open angle glaucoma (POAG) cohort, espe-
cially for the NTG subtype. Our ﬁnding correlates with the
previous ﬁndings where duplication in TBK1 is shown to be
associated with NTG in various populations.
Glaucoma is a neurodegenerative disease of the eye where
vision impairment occurs due to loss of retinal ganglion cells
(RGC) and if untreated culminates in irreversible blindness.
POAG is the most common subtype affecting ∼60 million
people worldwide (Quigley and Broman 2006). The most
important risk factor for POAG is higher intraocular pres-
sure (IOP) but almost 40% of the patients do not represent a
high IOP. Thus, POAG patients are usually subdivided into
HTG or NTG. Genetic basis of POAG is complex and in
addition to Mendelian forms of the disease, single-nucleotide
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polymorphism - genomewide association studies (SNP-GWAS)
as well as studies involving copy number variations (CNVs)
have been reported. Current knowledge on molecular basis
of POAG is described in a recent review (Janssen et al.
2013).
Among the POAG cases reported to harbour CNVs, a 780-kb
duplication on chromosome 12q14 was found to segregate
in a large family of African–American ethnicity for the
GLC1P locus with NTG phenotype (Fingert et al. 2011).
Subsequently, screening a larger cohort for this region nar-
rowed down the critical duplication interval to 300 kb which
spanned three genes, namely TBK1, XPOT and RASSF3
(Fingert et al. 2011; Kawase et al. 2012). In addition to the
African–American population, the duplication was found in
NTG patients of Australian, Caucasian and Japanese ethnic-
ities (Kawase et al. 2012; Awadalla et al. 2014; Ritch et al.
2014). To detect the most likely candidate genes inﬂuenced
by this duplication, a combination of three factors were
considered, namely (i) expression in retinal ganglion cells;
(ii) altered expression due to the duplication; and (iii)
involvement with known glaucoma genes. TBK1 satis-
ﬁed all the three criteria. Especially, TBK1 with duplica-
tion showed increased expression and was found to be a
direct interactor of optineurin (OPTN). E50K, the most well
known NTG-causing mutation in OPTN was shown to have
markedly enhanced binding afﬁnity to TBK1 (Minegishi
et al.2013). A recent study identiﬁed loss of function muta-
tion in TBK1 gene associated with familial amyotrophic
lateral sclerosis and frontotemporal dementia (Freischmidt
et al. 2015). It indicates that both gain and loss of func-
tion of TBK1 are detrimental and can lead to disease
phenotypes.
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In this study, we examined the presence of this speciﬁc
genomic variant in a glaucoma cohort from West Bengal,
India consisting of HTG and NTG subgroups.
Materials and methods
Selection criteria for study subjects
The inclusion criteria for patients with glaucoma was (i)
optic disc cupping or visual ﬁeld changes, open angle on
gonioscopy and an IOP>20 mm of Hg of glaucoma or (ii)
optic disc cupping and visual ﬁeld changes, open angle on
gonioscopy without elevated IOP. Patients of ocular hyper-
tension without any ﬁeld damage or cupping, and patients
with history of ocular trauma were excluded. The samples
were recruited after explaining the study to them individu-
ally with written consent. This study was approved by the
Table 1. Clinical information for patients with TBK1 duplication.
Patient ID Gender Age (years) IOP (RE) IOP (LE)
GL426 Male 54 15 13
GL582∗ Female 72 17.5 17.5
IOP, intraocular pressure measure in mm of Hg. RE, right eye; LE,
left eye.
∗Patient who also has cataract and hypertension. Both patients were
drug-naïve with respect to IOP lowering medication.
human ethics committee of the organization and followed
the tenets of declaration of Helsinki. Further, we had divided
our POAG cohort into NTG and HTG subgroups where
NTG selection criteria was IOP<20 mm of Hg in both eyes
(untreated) and for HTG, selection criteria was IOP>23 mm
of Hg in both eyes (untreated). The ﬁnal sample set had
158 NTG patients, 161 HTG patients (table 1 in electronic
supplementary material at http://www.ias.ac.in/jgenet/) and
197 controls recruited from a large population residing in
West Bengal, eastern part of India.
TBK1 duplication quantiﬁcation by Taqman assay
For a quantitative and speciﬁc assessment of this duplication
in our cohort of POAG patients, we used an established Taq-
Man assay (Fingert et al. 2011). Reactions were performed as
per the manufacturer’s protocol (Invitrogen, Carlsbad, USA).
The speciﬁc probes used were: (i) p/n 4403326: Taqman copy
number reference assay (human RNase P);(ii) p/n 4371355:
Genotyping master mix; (iii) hs06980763:h: TBK1-speciﬁc
copy number probe. Fold change was calculated by 2Ct
based method (Livak and Schmittgen 2001). Quantitative
PCR (qPCR) was conducted using 10 ng of DNA; PCR reac-
tions were performed using 5 μL of 2× TaqMan Genotyp-
ing Master Mix, 0.5 μL of TaqMan Copy Number Assay,
20× working stock and 0.5 μL of 20× TaqMan Copy
Number Reference Assay. The qPCR cycling protocol con-
sisted of 95◦C for 3 min; 40 cycles of 95◦C for 5 s, 60◦C for 5
s, 72◦C for 10 s. Experiments were conducted using ROCHE
Thermal Cycler LC480 (Indianapolis, USA).
Figure 1. TBK1 duplication in Indian POAG cohort. The ﬁgure represents copy number (vertical axis) of TBK1 gene
in NTG, HTG and control groups. Each data point represents individual samples. A value of 2.0 indicates normal copy
and 3.0 indicate duplication (three copies). The raw data supporting this ﬁgure can be found in table 2 in electronic
supplementary material. The two NTG samples found to have the duplication are marked by a red ellipse.
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Results and discussion
We found two NTG patients (table 1) who have the dupli-
cation for this region (copy-number change >1.5) with a
signiﬁcant P value (Grubb’s test for outliers, P <0.01). No
other controls or HTG patients showed fold change that
indicated duplication (ﬁgure 1). The clinical data of HTG
and NTG subgroups are provided in table 1 in electronic
supplementary material. Raw experimental values and
the fold change calculations for all the 465 samples
(143 NTG, 140 HTG and 182 controls) that passed
the experimental quality criteria are provided in table 2
in electronic supplementary material. Our study supports
the fact that the TBK1 duplication is indeed absent in
HTG patients thus conﬁrming its speciﬁcity for the NTG
subgroup.
TBK1 gene encodes a kinase that interacts with the TANK
protein (IKK subfamily member), involved in NFκB sig-
nalling pathway. It has been reported that in response to
TNFα, OPTN interacts with TBK1 and recruits it to K63-
pUb-RIP (receptor interacting protein) complex which acti-
vates NFκB signalling (Morton et al. 2008). Previous study
on glaucomatous astrocytes has shown increased expression
of NFκB signalling and TNFα (Nikolskaya et al. 2009).
TNFα activates NFκB signalling and has been reported that
upregulation of TNFα causes damage to optic nerve head in
the POAG patients (Morton et al. 2008). Previous studies
have reported that NFκB play a key role in autophagy regu-
lation and duplication in TBK1 gene causes increased NFκB
signalling which contributes the induction of autophagy and
thus connecting TBK1 to the biology of glaucomatous neu-
rodegeneration (Trocoli and Djavaheri-Mergny 2011). Our
previous work on genome-wide copy number variation for
large CNVs in POAG did not detect any CNV in this region
due to absence of probes in the microarray platform (Kaurani
et al. 2014). It is noteworthy that this duplication is also
absent in the database of genomic variants (http://dgv.tcag.
ca/dgv/app/home) from global population, thus highlighting
its detrimental effect. Interestingly, in all the different popu-
lations in which this duplication is reported so far is always
found to be speciﬁc to the NTG subgroup and the duplica-
tion frequencies are also consistent (1–2%). In the ﬁeld of
glaucoma genetics, myocilin (MYOC) is the gene that is most
frequently mutated in every population studied so far includ-
ing India. The frequency of MYOC mutations is 3–4% across
the globe when checked in cohorts of sporadic patients of
glaucoma. Thus, although the TBK1 duplication has a low
frequency, given the complexity of the genetic aetiology of
glaucoma, this seems to be a very important genetic defect
that is so far found in each population studied with a con-
sistent frequency and very high speciﬁcity only for the NTG
subgroup.
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